Accumen Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
173
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
4
Accumen General Information
Description
Provider of health system performance optimization services intended to serve hospitals and the healthcare industry. The company offers to consult on strategic growth and execution, utilization enhancements and performance measurement, lab and imaging transformation, supply chain optimization and clinical data exchange, enabling clients to deliver patient care through evidence-based data and clinical decision support capabilities.
Contact Information
Website
www.accumen.com(Operating Subsidiary)
Corporate Office
- 3333 North Hayden Road
- Suite 1
- Scottsdale, AZ 85251
- United States
Corporate Office
- 3333 North Hayden Road
- Suite 1
- Scottsdale, AZ 85251
- United States
Accumen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Accumen Comparisons
Industry
Financing
Details
Accumen Competitors (4)
One of Accumen’s 4 competitors is Optum, a Private Equity-Backed company based in Eden Prairie, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Optum | Private Equity-Backed | Eden Prairie, MN | ||||
| TRIARQ Health | Formerly Angel backed | Royal Oak, MI | ||||
| Amedeon Health | Corporation | London, United Kingdom | ||||
| Infusystem Holdings | Corporation | Rochester Hills, MI |
Accumen Patents
Accumen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200365274-A1 | Healthcare data ingestion and analysis system and method | Inactive | 03-Feb-2017 | ||
| EP-3770912-A1 | Methods and devices for improving quality of life and function in chronic disease | Inactive | 02-Feb-2010 | ||
| CA-2788650-A1 | Methods and devices for reducing transfusions during or after surgery and for improving quality of life and function in chronic disease | Active | 02-Feb-2010 | ||
| CA-2788650-C | Methods and devices for reducing transfusions during or after surgery and for improving quality of life and function in chronic disease | Active | 02-Feb-2010 | ||
| EP-2531097-A1 | Methods and devices for reducing transfusions during or after surgery and for improving quality of life and function in chronic disease | Active | 02-Feb-2010 | G16H50/30 |
Accumen Signals
Accumen Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Accumen Investments & Acquisitions (4)
Accumen’s most recent deal was a Buyout/LBO with 3DR Labs. The deal was made on 21-Oct-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 3DR Labs | 21-Oct-2019 | Buyout/LBO | Laboratory Services (Healthcare) | ||
| MyBloodHealth | 19-Aug-2019 | Buyout/LBO | Buildings and Property | ||
| Halfpenny Technologies | 14-Jun-2019 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| CHI Solutions | 05-Apr-2016 | Buyout/LBO | Laboratory Services (Healthcare) |
Accumen Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| 3DR Labs | Louisville, KY |
Accumen FAQs
-
When was Accumen founded?
Accumen was founded in 2011.
-
Where is Accumen headquartered?
Accumen is headquartered in Scottsdale, AZ.
-
What is the size of Accumen?
Accumen has 173 total employees.
-
What industry is Accumen in?
Accumen’s primary industry is Practice Management (Healthcare).
-
Is Accumen a private or public company?
Accumen is a Private company.
-
What is Accumen’s current revenue?
The current revenue for Accumen is .
-
Who are Accumen’s investors?
Accretive and Arsenal Capital Partners have invested in Accumen.
-
Who are Accumen’s competitors?
Optum, TRIARQ Health, Amedeon Health, and Infusystem Holdings are competitors of Accumen.
-
When was Accumen acquired?
Accumen was acquired on 22-Oct-2024.
-
Who acquired Accumen?
Accumen was acquired by hc1 IQ.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process